Olanzapine in the long-term treatment of bipolar disorder: A systematic review and meta-analysis
Cipriani et al.
J Psychopharmacol 2010;24:1729-1738.
ABSTRACT
Minimal-medication approaches to treating schizophrenia
Calton and Spandler
Adv. Psychiatr. Treat. 2009;15:209-217.
ABSTRACT
| FULL TEXT
A Systematic Review of the Soteria Paradigm for the Treatment of People Diagnosed With Schizophrenia
Calton et al.
Schizophr Bull 2008;34:181-192.
ABSTRACT
| FULL TEXT
Continued Controversies: Issues in Mental Health Research and Implications for Nursing
Spath
J Am Psychiatr Nurses Assoc 2007;13:221-229.
ABSTRACT
Integrated Treatment and Implications for Off-Medication Periods
Cullberg
Schizophr Bull 2006;32:299-299.
FULL TEXT
Can Medication-Free Research Ever Be Ethical in Older People With Psychotic Disorders?
Jeste
Schizophr Bull 2006;32:303-304.
FULL TEXT
Ethics of Medication-Free Research in Schizophrenia
Chen and Moreno
Schizophr Bull 2006;32:307-309.
FULL TEXT
Implications for Future Research of "Medication-Free Research in Early Episode Schizophrenia"
Schooler
Schizophr Bull 2006;32:297-298.
FULL TEXT
Editorial: Traditional Ethics and New Sensitivities
Carpenter
Schizophr Bull 2006;32:1-2.
FULL TEXT
A Summary of Important Documents in the Field of Research Ethics
Fischer
Schizophr Bull 2006;32:69-80.
ABSTRACT
| FULL TEXT
Emerging Empirical Evidence on the Ethics of Schizophrenia Research
Dunn et al.
Schizophr Bull 2006;32:47-68.
ABSTRACT
| FULL TEXT
Ethical Concerns in Schizophrenia Research: Looking Back and Moving Forward
Wilson and Stanley
Schizophr Bull 2006;32:30-36.
FULL TEXT
Ethical Issues in Schizophrenia Research: A Commentary on Some Current Concerns
Shore
Schizophr Bull 2006;32:26-29.
ABSTRACT
| FULL TEXT
Do Research Procedures Pose Relatively Greater Risk for Healthy Persons Than for Persons With Schizophrenia?
Roberts et al.
Schizophr Bull 2006;32:153-158.
ABSTRACT
| FULL TEXT
Control Group Bias in Randomized Atypical Antipsychotic Medication Trials for Schizophrenia
Woods et al.
Arch Gen Psychiatry 2005;62:961-970.
ABSTRACT
| FULL TEXT
Placebo or Active Control Trials of Antipsychotic Drugs?
Fleischhacker et al.
Arch Gen Psychiatry 2003;60:458-464.
ABSTRACT
| FULL TEXT
Placebo-Controlled Trials and Active-Control Trials in the Evaluation of New Treatments. Part 2: Practical Issues and Specific Cases
Ellenberg and Temple
ANN INTERN MED 2000;133:464-470.
ABSTRACT
| FULL TEXT
Evidence-Based Ethics and Informed Consent in Mental Illness Research
Roberts
Arch Gen Psychiatry 2000;57:540-542.
FULL TEXT
Addressing Ethical Issues in the Psychiatric Research Literature
Miller et al.
Arch Gen Psychiatry 1999;56:763-764.
FULL TEXT
Does a four-week delay in the introduction of medication alter the course of functional psychosis?
Johnstone et al.
J Psychopharmacol 1999;13:238-244.
ABSTRACT
Professional Integrity in Clinical Research
Miller et al.
JAMA 1998;280:1449-1454.
ABSTRACT
| FULL TEXT
Are Medication-Free Periods Necessary for Phase 3 Trials of New Antipsychotic Drugs?
Volavka
Arch Gen Psychiatry 1998;55:280-281.
FULL TEXT
Medication Removal and Research in Psychotic Disorders
Baldessarini et al.
Arch Gen Psychiatry 1998;55:281-283.
FULL TEXT
Medication-Free Research With Schizophrenic Patients: A European Perspective
Henn et al.
Arch Gen Psychiatry 1997;54:412-413.
ABSTRACT
The Call of the Sirens: Navigating the Ethics of Medication-Free Research in Schizophrenia
Fins and Miller
Arch Gen Psychiatry 1997;54:415-416.
ABSTRACT
